Errors of prescription, transcription and administration according to pharmacological group at hospital
e201901004
Keywords:
Medication errors, Pharmacological groups, Adverse events, Prescription, Transcription, AdministrationAbstract
Background: Most studies of medication errors are focused only on finding global prevalence by patients, by phases or according to a certain group of medication. It’s just a partial view of the problem. To analyze and compare the prevalence of errors in prescription, transcription and administration, and their clinical repercussions in different pharmacological groups in a third-level hospital.
Methods: Prospective inclusion study with direct observation disguised as medication administration and comparison with prescriptions and transcriptions at history clinical. The ME and its clinical effects were classified by expert consensus. We calculated the different error rates and their repercussions with their confidence intervals at 95%. Then we compared using Chi-square tests.
Results: We studied 5,578 prescribed drugs and we observed the administration of 1,879 doses. A total of 117 different pharmacological groups were found, although 50.1% of the prescriptions (2,795) belonged to only 9 types. We found heparins had a lower prevalence of errors in prescription and transcription and aspirin also had a lower prevalence of prescription errors. On the opposite side, a greater number of errors were obtained in transcription of Paracetamol, Metamizole and Laxatives and a prevalence of errors in the administration phase superior to rest in Paracetamol and in Proton Pump Inhibitors. The impact of medication error increased as medication process progressed, being similar between groups in prescription. In transcription, Heparins and Corticosteroids presented more serious errors. In administration, medication error are more serious for Diuretics and Statins (p<0.05).
Conclusions: Drugs considered potentially dangerous present fewer errors (Heparins, Corticoids), but more serious. Drugs with the highest prevalence of errors were Paracetamol and Inhibitors of proton pump but had a lower impact.
Downloads
References
Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991; 324:370-76.
Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991; 324:377-84.
Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ. 2001; 322:517-19.
Davis P, Lay-Yee R, Schug S, Briant R, Scott A, Johnson S, et al. Adverse events regional feasibility study: indicative findings. N Z Med J. 2001; 114:203-5.
Aranaz JM por el Grupo de Estudio del Proyecto IDEA. Proyecto IDEA: Identificación de efectos adversos. Rev Calidad Asistencial. 204;19:14-8.
Otero MJ, Codina C, Tamés MJ, Pérez M. Errores de medicación: estandarización de la Terminología y clasificación. Farm Hosp. 2003; 27:137-49.
Linsky A, Simon RS. Medication discrepancies in integrated electronic health records. BMJ Qual Saf. 2013; 22:103–9.
Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett M. Improving Electronic Oral Chemotherapy Prescription: Can We Build a Safer System?. J Oncol Pract. 2012; 8: 168-73.
Sakushimaa K, Umekib R, Endohb A, Itoc Y, Nasuharad Y. Time trend of injection drug errors before and after implementation of bar-code verification system. Technol Health Care. 2015; 23:267-74.
Berdot S, Sabatier B, Gillaizeau F, Caruba T, Prognon P, Durieux P. Evaluation of drug administration errors in a teaching hospital. BMC Health Services Research [on line] 2012, 12 de marzo [fecha de acceso 28 de febrero de 2018]; 12 (60). URL Disponible en: http://www.biomedcentral.com/1472-6963/12/60.
United States Pharmacopeia Convention. [Internet]. Usp.org. 2016 [fecha de acceso 1 Agosto 2016]. Disponible en: http://www.usp.org.
Otero López MJ, Codina Jané C, Tamés Alonso MJ, Pérez Encinas M. Errores de medicación: estandarización de la terminología y clasificación. Resultados de la Beca Ruiz-Jarabo 2000. Farm Hosp.2003; 27:137-49.
National Coordinating Council for Medication Error Reporting and Prevention. NCCMERP. Taxonomy of medications errors [Internet]. nccmerpsq.org. 2016 [fecha de acceso 1 Agosto 2016]. Disponible en: http://www.nccmerp.org.
Tully MP. Prescribing errors in hospital practice. Br J Clin Pharmacol 2012; 74: 668–75.
Odukoyaa OK, Stone JA, Chuib MA. E-prescribing errors in community pharmacies: Exploring consequences and contributing factors. Int J Med Inform. 2014; 83:427-37.
Esteban Jiménez O, Navarro Pemán C, González Rubio F, Lanuza Giménez FJ, Montesa Lou C. Análisis de la incidencia y de las características clínicas de las reacciones adversas a medicamentos de uso humano en el medio hospitalario. Rev Esp Salud Pública. Research [on line] 2017,22 de diciembre [fecha de acceso 28 de febrero de 2018].URL Disponible en: www.msc.es/resp.
Linsky A, Simon RS. Medication discrepancies in integrated electronic health records. BMJ Qual Saf. 2013; 22:103–9.
Abdel-Qader DH, Harper L, Cantrill JA, Tully MP. Pharmacists’ interventions in prescribing errors at hospital discharge. An observational study in the context of an electronic prescribing system in a UK teaching hospital. Drug Saf. 2010; 33 : 1027-44.
Singh H, Mani S, Espadas D, Petersen N, Franklin V, Petersen LA. Prescription errors and outcomes related to inconsistent information transmitted through computerized order entry. Arch Intern Med. 2009 ; 169: 982-9.
Pastó-Cardona L , Masuet-Aumatell C, Bara-Oliván B, Castro-Cels I, Clopés-Estela A, Pàez-Vives F, Schönenberger-Arnaiz JA, Gorgas-Torner MQ, Codina-Jané C. Estudio de incidencia de los errores de medicación en los procesos de utilización del medicamento: prescripción, transcripción, validación, preparación, dispensación y administración en el ámbito hospitalario. Farmacia Hosp. 2009; 33 :257-68
Institute for Safe Medication Practice. [fecha de acceso 28 de febrero de 2018]. Disponible en https://www.ismp.org/.
Estrategia de Seguridad del Paciente del Sistema Nacional de Salud. Período 2015-2020. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2016.
Joint Commission on Accreditation of Healthcare Organization. National Patient Safety Goals. Joint Commission. 2015. [fecha de acceso 28 de febrero de 2018]. Disponible en: http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals89.
Eluri M, Spiller HA, Casavant MJ, Chounthirath T, Conner KA, Smith GA Analgesic-Related Medication Errors Reported to US Poison Control Centers. Pain Med. Research [on line] 2017, 23 de noviembre [fecha de acceso 28 de febrero de 2018].URL Disponible en: https://doi.org/10.1093/pm/pnx272.
Niedrig DF, Hoppe L, Mächler S, Russmann H, Russmann S. Benzodiazepine Use During Hospitalization: Automated Identification of Potential Medication Errors and Systematic Assessment of Preventable Adverse Events. PLoS One. Research [on line] 2016, 6 de Octubre [fecha de acceso 28 de febrero de 2018].URL Disponible en: https://doi.org/10.1371/journal.pone.0163224.
Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies. Mayo Clin Proc. 2016;91:1632-9.
Desai RJ, Williams CE, Greene SB, Pierson S, Caprio AJ, Hansen RA. Exploratory evaluation of medication classes most commonly involved in nursing home errors. J Am Med Dir Assoc. 2013;14:403-8.
Waltering I, Schwalbe O, Hempel G. Discrepancies on Medication Plans detected in German Community Pharmacies. J Eval Clin Pract. 2015 ; 21:886-92.
Maaskant J, Bosman D, van Rijn-Bikker P, van Aalderen W, Vermeulen H. Preventable errors with nonopioid analgesics and antiemetic drugs may increase burden in surgical pediatric patients. Eur J Pediatr Surg. 2014 ;24:381-8.
Gandhi TJ, Bartel SB M.H.P, Shulman LN, Verrier D, Burdick E, Cleary A, Rothschild JM, Leape LL, Bates DW. Medication safety in the ambulatory chemotherapy setting. Cancer.2005; 104:2477-83.
Bedouch P, Sylvoz N, Charpiat B, Juste M, Roubille R, Rose FX , Bosson JL, Conort O, Allenet B and the French Society of Clinical Pharmacy’s Act-IP© Group. Trends in pharmacists’ medication order review in French hospitals from 2006 to 2009: analysis of pharmacists’ interventions from the Act-IP© website observatory. J Clin Pharm Ther. 2015; 40: 32–40.
Folli H, Poole RL, Benitz WE, Russo JC. Medication Error Prevention by Clinical Pharmacists in Two Children’s Hospitals. Pediatrics. 1987; 79: 718-22.
Ahuva Lustig. Medication error prevention by pharmacists. An Israeli solution. Pharm World Sci. 2000; 22: 21-5.
Causal R, Bates DW, Landrigan C; et al. Medication Errors and Adverse Drug Events in Pediatric Inpatients. JAMA. 2001; 285:2114-20.
Lisby M, Nielsen LP, Brock B,Mainz J. How are medication errors defined? A systematic literature review of definitions and characteristics. Int J Qual Health Care. 2010; 22: 507–18.
Otero MJ, Moreno-Gómez AM, Santos-Ramos B, Agra Y. Developing a list of high-alert medications for patients with chronic diseases. Eur J Intern Med. 2014;25:900-8.
Maher RL, Hajjar ER. Medication errors in the ambulatory elderly. AGING HEALTH. 2012; 8 :127-35.
Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, Elliott RA, Howard R, Kendrick D, Morris CJ, Prescott RJ,Swanwick G, Franklin M, Putman K, Boyd M, Sheikh A. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012 ; 379: 136–42.
Ohashi K, Dalleur O, Dykes PC, Bates DW. Benefits and risks of using smart pumps to reduce medication error rates: a systematic review. Drug Saf. 2014 ;37: 1011-20.
Beaudoin FL, Merchant RC, Janicki A, McKaig DM, Babu KM. Preventing iatrogenic overdose: a review of in-emergency department opioid-related adverse drug events and medication errors. Ann Emerg Med. 2015;65:423-31.
Barker KN, McConell WE. The problem of detecting medication errors in hospitals. Am J Hosp Pharm 1962; 19:361-9.
Downloads
Published
How to Cite
License
Copyright (c) 2019 Ana Belén Jiménez Muñoz, Belén Martínez Mondéjar, Antonio Muiño Míguez, Dulce Romero Ayuso, Gema María Saiz Ladera, Juan José Criado Álvarez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
